Intercept Pharmaceuticals, Inc.
NASDAQ:ICPT
19 (USD) • At close November 7, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 50.517 | 84.709 | 58.151 | 70.055 | 436.16 | 414.917 | 689.385 | 628.055 | 239.724 | 13.363 | 110.194 | 17.707 |
| Short Term Investments
| 435.049 | 334.98 | 411.516 | 582.567 | 392.912 | 344.904 | 645.71 | 595.313 | 219.701 | 131.547 | 64.759 | 0 |
| Cash and Short Term Investments
| 490.909 | 429.389 | 477.17 | 657.347 | 436.16 | 414.917 | 689.385 | 628.055 | 239.724 | 144.91 | 110.194 | 17.707 |
| Net Receivables
| 26.862 | 47.617 | 41.549 | 38.044 | 25.694 | 18.572 | 12.335 | 3.691 | 2.557 | 1.378 | 0.537 | 0.637 |
| Inventory
| 6.462 | 8.619 | -68.571 | 8.462 | 7.108 | 0 | 2.279 | -3.644 | 3.547 | 1.277 | 0.036 | 0.359 |
| Other Current Assets
| 22.356 | 25.286 | 27.022 | 25.924 | 20.571 | 16.889 | 9.354 | 13.591 | 0 | -0 | 1.011 | 0.201 |
| Total Current Assets
| 540.127 | 502.292 | 477.17 | 721.315 | 482.425 | 448.307 | 707.865 | 641.693 | 245.828 | 147.565 | 111.778 | 18.904 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 0.987 | 9.496 | 18.653 | 18.448 | 10.411 | 16.184 | 11.295 | 10.047 | 5.851 | 1.672 | 0.149 | 0.311 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 12.597 | 15.235 | 84.666 | 15.123 | 16.331 | 19.856 | 20.093 | 4.018 | 2.469 | 1.082 | 0.252 | 0.255 |
| Total Non-Current Assets
| 13.584 | 24.731 | 103.319 | 33.571 | 26.742 | 36.04 | 31.388 | 14.065 | 8.32 | 2.754 | 0.4 | 0.566 |
| Total Assets
| 553.711 | 527.023 | 580.489 | 754.886 | 509.167 | 484.347 | 739.253 | 655.758 | 254.149 | 150.319 | 112.179 | 19.47 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 14.234 | 18.132 | 24.594 | 18.975 | 11.765 | 6.965 | 6.722 | 4.17 | 3.129 | 3.196 | 1.18 | 0.604 |
| Short Term Debt
| 109.569 | 3.042 | 7.248 | 6.456 | 82.491 | 0 | 0 | 0 | 10.33 | 4.064 | 2.566 | 0.082 |
| Tax Payables
| 3.144 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 136.691 | 138.292 | 130.535 | 1.621 | 1.782 | 5.694 | 1.782 | 1.782 | 1.622 | 1.622 | 2.446 |
| Other Current Liabilities
| 106.274 | 8.952 | 8.942 | 6.039 | 18.328 | 95.287 | 66.096 | 41.421 | 0 | -0 | 7.597 | 0.9 |
| Total Current Liabilities
| 230.077 | 166.817 | 179.076 | 162.005 | 114.205 | 104.034 | 78.512 | 47.373 | 15.241 | 8.881 | 12.964 | 4.032 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 223.104 | 544.168 | 568.266 | 532.078 | 371.25 | 355.677 | 341.356 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 2.432 | 4.454 | 10.147 | 8.017 | 9.799 | 8.919 | 12.162 | 12.162 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | -1.621 | -1.782 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 7.453 | 0 | 0 | 9.247 | 3.771 | 5.578 | -5.694 | -1.781 | -1.782 | 50.112 | 21.141 | 5.836 |
| Total Non-Current Liabilities
| 230.557 | 544.168 | 568.266 | 541.325 | 375.832 | 363.927 | 345.809 | 6.236 | 8.017 | 59.031 | 33.303 | 17.998 |
| Total Liabilities
| 460.634 | 710.985 | 747.342 | 703.33 | 490.037 | 467.961 | 424.321 | 53.609 | 23.258 | 67.912 | 46.267 | 22.03 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.028 |
| Common Stock
| 0.042 | 0.03 | 0.033 | 0.033 | 0.03 | 0.025 | 0.025 | 0.024 | 0.021 | 0.019 | 0.017 | 0.003 |
| Retained Earnings
| -2,136.888 | -2,489.772 | -2,398.346 | -2,123.466 | -1,778.785 | -1,469.543 | -1,108.46 | -695.63 | -469.202 | -185.976 | -118.183 | -74.54 |
| Accumulated Other Comprehensive Income/Loss
| -8.256 | -2.873 | -2.477 | -1.144 | -2.259 | -0.786 | -2.801 | -2.253 | -0.284 | 0.06 | -0.021 | -0.185 |
| Other Total Stockholders Equity
| 2,238.179 | 2,308.653 | 2,233.937 | 2,176.133 | 1,800.144 | 1,486.69 | 1,426.168 | 1,300.008 | 700.355 | 268.303 | 184.1 | 72.134 |
| Total Shareholders Equity
| 93.077 | -183.962 | -166.853 | 51.556 | 19.13 | 16.386 | 314.932 | 602.149 | 230.891 | 82.406 | 65.912 | -2.56 |
| Total Equity
| 93.077 | -183.962 | -166.853 | 51.556 | 19.13 | 16.386 | 314.932 | 602.149 | 230.891 | 82.406 | 65.912 | -2.56 |
| Total Liabilities & Shareholders Equity
| 553.711 | 527.023 | 580.489 | 754.886 | 509.167 | 484.347 | 739.253 | 655.758 | 254.149 | 150.319 | 112.179 | 19.47 |